Results 161 to 170 of about 57,560 (274)

Antimicrobial Resistance Patterns and Predictors in <i>Helicobacter pylori</i> Infection: A Real-World Cohort Study. [PDF]

Microorganisms
Matei SD, Suciu RN, Ilias T, Avram GA, Suteu C, Bondar LI, Hocopan C, Pantis C, Fazakas R, Frățilă O.   +9 more
europepmc   +1 more source

A Successfully Treated Case of <i>Mycobacterium chelonae</i> Pulmonary Infection and a Literature Review (1990-2025). [PDF]

Infect Drug Resist
Qi B, Wang C, Wei X, Li Y, Li Y, Yao Y, Wei S, Ning S, Du X, Jin Y, Yang R, Chen X, Ge P, Sun B.   +13 more
europepmc   +1 more source

Pharmacokinetic Drug-Drug Interactions of DA-8010 with Clarithromycin or Rifampicin: Influence of CYP2D6 Phenotype on the Extent of These Interactions. [PDF]

Drug Des Devel Ther
Lee S, Won H, Yu KS, Lee DY, Lee S.
europepmc   +1 more source

Studies in design and development of stomach specific drug delivery system using various approaches

, 2010
Not ...
Chavda, Jayanti R.
core  

Rare Complications in Crohn's Disease: Diagnostic and Therapeutic Challenge of Dermal Abscesses Caused by Nontuberculous Mycobacteria Following Infliximab Therapy, and Fluoroquinolone-Related Achilles Tendon Rupture. [PDF]

Am J Case Rep
Gupta N, Yadav K, Carter A, Karimian B, Almonte C, Sampath R.   +5 more
europepmc   +1 more source

Clinical utility of fecal Sanger sequencing and PCR alongside gastric biopsy E-test for <i>Helicobacter pylori</i> resistance to clarithromycin and quinolone. [PDF]

Microbiol Spectr
Xu J, Peng L, Hu H, Zhao Y, Li W, Peng H, Zhou C.   +6 more
europepmc   +1 more source

Macrolide-induced hypersensitivity reactions in the pediatric population. [PDF]

Ital J Pediatr
Caimmi S, Liotti L, Riscassi S, Rosset G, Bottau P, Bianchi A, Crisafulli G, Franceschini F, Mori F, Saretta F, Valluzzi RL, Buono EV, Marseglia GL, Caffarelli C.   +13 more
europepmc   +1 more source

Molecular pathways driving clarithromycin benefit in community-acquired pneumonia: analysis of the ACCESS randomised trial. [PDF]

EBioMedicine
Stylianakis E, Kakavoulis N, Foutadakis S, Koufargyris P, Niotis G, Akinosoglou K, Iliopoulou K, Kotsaki A, Chatzopoulos M, Skorda L, Tzavara V, Chrysos G, Gerakari S, Katsaounou P, Kontopoulou T, Dalekos GN, Kumar V, Netea MG, Torres A, Niederman M, Giamarellos-Bourboulis EJ.   +20 more
europepmc   +1 more source

Ten-Year Trends in First- and Second-Line <i>Helicobacter pylori</i> Eradication Rates at a Regional Hospital in Japan. [PDF]

Juntendo Med J
Shimada Y, Hojo M, Nago H, Yamaguchi M, Kato Y, Om R, Terai Y, Kita Y, Ikeda Y, Sato S, Murata A, Sato S, Nagahara A, Genda T.   +13 more
europepmc   +1 more source

Development of Keystone Macrolide Antibiotics via Selective Oxidation. [PDF]

ACS Cent Sci
Moore E, Fraley AE.
europepmc   +1 more source